RSPHvsXLVETF Comparison
VS
Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.08% for XLV. RSPH is up 9.66% year-to-date (YTD) with -$43M in YTD flows. XLV performs worse with 5.9% YTD performance, and +$168M in YTD flows. Run a side-by-side ETF comparison of RSPH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
RSPH vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/31/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | RSPH XLV | +3.38%+1.86% | +15.20%+12.45% | +9.66%+5.90% | +25.54%+26.79% | +18.66%+27.43% | +16.51%+33.18% |
| Flows | RSPH XLV | +$29M+$165M | -$12M-$364M | -$43M+$168M | -$67M+$1.50B | -$347M-$5.37B | -$250M+$2.27B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | RSPH XLV | +18.03%+18.64% | +15.92%+15.66% | +15.40%+14.41% | +16.57%+15.03% |
| Max drawdown | RSPH XLV | -3.58%-3.83% | -10.87%-10.51% | -16.96%-17.05% | -21.91%-17.05% |
| Max drawdown duration | RSPH XLV | 20d20d | 116d116d | 434d444d | 817d444d |
Trading data
RSPH | XLV | |
Last sale 8/3/2026 at 3:39 PM | $35.09 | $162.17 |
| Previous close 07/31/2026 | $34.76 | $162.55 |
| Consolidated volume 07/31/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of July 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
RSPH | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 8/3/2026 at 3:39 PM
Live
Closed
RSPH | XLV | |
|---|---|---|
| Last price | $35.09 | $162.17 |
| 1D performance | +0.95% | -0.23% |
| AuM | $766.87 M | $41.75 B |
| E/R | 0.4% | 0.08% |
Characteristics
RSPH | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | State Street Investment Management |
| Benchmark | S&P 500 Equal Weight Health Care Index | S&P Health Care Select Sector Index |
| N° of holdings | 59 | 59 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2006 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
RSPH
USA
96.71%
Other
3.29%
XLV
USA
97.92%
Other
2.08%
Sectors
RSPH
Healthcare
98.29%
Other
1.71%
XLV
Healthcare
97.73%
Other
2.27%
Advertisement
Diversification
RSPH
Total weight of top 15 holdings out of 15
27.58%
XLV
Total weight of top 15 holdings out of 15
72.82%
Top 15 holdings
Data as of June 30, 2026
RSPH
Moderna, Inc.
2.35%
Bio-Techne Corp.
2.17%
Charles River Laboratories International, Inc.
1.86%
Vertex Pharmaceuticals, Inc.
1.81%
AbbVie, Inc.
1.81%
Mettler-Toledo International, Inc.
1.79%
Revvity, Inc.
1.79%
Biogen, Inc.
1.79%
Cardinal Health, Inc.
1.77%
DaVita, Inc.
1.76%
Baxter International, Inc.
1.74%
Merck & Co., Inc.
1.74%
Incyte Corp.
1.73%
Henry Schein, Inc.
1.73%
Stryker Corp.
1.73%
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
Frequently asked questions about RSPH and XLV
How have the RSPH and XLV ETFs performed in 2026?
As of July 31, 2026, RSPH is up 9.66% year-to-date (YTD), while XLV has returned 5.9%. That puts RSPH better performer ahead so far this year.
Which ETF is attracting more investor money: RSPH or XLV?
Year-to-date, the RSPH ETF saw -$43M in flows, compared to +$168M for XLV.
Which ETF is more volatile: RSPH or XLV?
Over the past year, RSPH had a volatility of 15.92%, while XLV experienced 15.66%.
Which ETF is bigger: RSPH or XLV?
As of July 31, 2026, RSPH holds $766.87 M in assets under management (AUM), while XLV manages $41.75 B.
What sectors do the RSPH and XLV ETFs invest in?
RSPH leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the RSPH ETF and XLV ETF?
RSPH top holdings include Moderna, Inc., Bio-Techne Corp. and Charles River Laboratories International, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: RSPH or XLV?
RSPH holds 59 securities with 27.58% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 72.82%.
Advertisement
Latest news about RSPH & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Tony's ETF Buyers Guide: Equal-Weight ETFs
May 14, 2024
RSPH
Tony's ETF Buyers Guide: Equal-Weight ETFs
May 14, 2024
RSPH
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
RSPH
Spotlight on Market Valuations: Sector Comparisons and ETF Opportunities
March 14, 2024
RSPH
Advertisement
